德国初级保健机构中甲状腺细针穿刺细胞学检查的低恶性率
该研究回顾性分析德国初级保健机构中8380例患者的9460次甲状腺结节细针穿刺(FNA)细胞学检查,按Bethesda系统分类。结果显示恶性、可疑恶性、滤泡性肿瘤/可疑滤泡性肿瘤及意义不明确的不典型/意义不明确的滤泡性病变比例较低,而囊肿/囊性结节比例较高;各类别的恶性风险与Bethesda推荐一致。
要点
- 初级保健机构FNA细胞学中恶性、可疑恶性、FN/SFN和AUS/FLUS比例较低,囊肿/囊性结节比例较高。
- AUS/FLUS、FN/SFN、SFM和恶性的观察恶性风险分别为22%/8%、69%/17%、78%/86%和71%/98%。
- 以组织学为金标准,112例细胞学可疑和恶性FNA中真阳性102例、假阳性10例。
核心结论
- 在德国初级保健机构中,恶性、可疑恶性、FN/SFN和AUS/FLUS的百分比低,而囊肿/囊性结节的百分比高,与其他主要来自三级中心的数据不同。
- 恶性、SFM、AUS/FLUS和FN/SFN FNA细胞学的恶性风险符合Bethesda推荐。
研究设计与样本
- 回顾性分析德国初级保健机构中8380例患者的9460次甲状腺结节FNA细胞学检查,由一位细胞学家(I.R.)在两年期间评估,FNA由64名医生在不同私人诊所实施。
主要发现
- 细胞病理结果按Bethesda系统分类:非诊断性19%,囊肿/囊性结节21%,良性(包括甲状腺炎)48%,AUS/FLUS 6%,FN/SFN 4%,SFM 1%,恶性1%。
- 接受手术或至少随访一年的患者比例及观察到的恶性风险分别为:AUS/FLUS 22%/8%,FN/SFN 69%/17%,SFM 78%/86%,恶性71%/98%。
- 以组织学为金标准,112例细胞学可疑和恶性FNA中,真阳性102例,假阳性10例。
关键数值与推荐
- Bethesda分类比例:非诊断性19%,囊肿/囊性结节21%,良性(包括甲状腺炎)48%,AUS/FLUS 6%,FN/SFN 4%,SFM 1%,恶性1%。
- 观察到的恶性风险:AUS/FLUS 8%,FN/SFN 17%,SFM 86%,恶性98%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reported results for thyroid nodule fine-needle aspiration (FNA) cytology mainly originate from tertiary centers. However, thyroid nodule FNA cytology is mainly performed in primary care settings for which the distribution of FNA Bethesda categories and their respective malignancy rates are largely unknown. Therefore, this study investigated FNA cytology malignancy rates of a large primary care setting to determine to what extent current evidence-based strategies for the malignancy risk stratification of thyroid nodules are applied and applicable in such primary care settings. METHODS: In a primary care setting, 9460 FNAs of thyroid nodules were retrospectively analyzed from 8380 patients evaluated by one cytologist (I.R.) during a period of two years. The 8380 FNA cytologies were performed by 64 physicians in different private practices throughout Germany in primary care settings. RESULTS: The cytopathologic results were classified according to the Bethesda System as non-diagnostic in 19%, cyst/cystic nodule in 21%, benign (including thyroiditis) in 48%, atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) in 6%, follicular neoplasms/suspicious for follicular neoplasm (FN/SFN) in 4%, suspicious for malignancy (SFM) in 1%, and malignant in 1%. The proportion of patients proceeding to surgery or with a follow-up of at least one year and the observed risks of malignancy were 22%/8% for AUS/FLUS, 69%/17% for FN/SFN, 78%/86% for SFM, and 71%/98% for malignant. For 112 cytologically suspicious and malignant FNAs, there were 102 true positives and 10 false positives, considering histology as gold standard. CONCLUSION: At variance with other data mostly originating from tertiary centers, these data demonstrate low percentages for malignant, SFM, FN/SFN, and AUS/FLUS, and high percentages for cysts/cystic nodules in this primary care setting in Germany. The risks of malignancy for malignant, SFM, AUS/FLUS, and FN/SFN FNA cytologies are according to Bethesda recommendations.
引用
- Eszlinger M, Ullmann M, Ruschenburg I, et al. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany. Thyroid. 2017. PMID: 28982301. doi:10.1089/thy.2017.0167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。